LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
48.60
+1.66 (3.54%)
At close: Oct 8, 2025, 4:00 PM EDT
47.65
-0.95 (-1.95%)
After-hours: Oct 8, 2025, 6:26 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $1.39 billion as of October 8, 2025. Its market cap has increased by 125.16% in one year.
Market Cap
1.39B
Enterprise Value
1.18B
1-Year Change
125.16%
Ranking
Category
Stock Price
$48.60
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $1.39B, an increase of 235.11%. That is a compound annual growth rate of 118.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1.34B | 68.63% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |